Samil Pharmaceutical Co.,Ltd (KRX:000520)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,400.00
+310.00 (4.37%)
Last updated: Jun 4, 2026, 2:24 PM KST

KRX:000520 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,1886,4125,137906.141,9033,992
Short-Term Investments
-----11,269
Cash & Short-Term Investments
1,1886,4125,137906.141,90315,261
Cash Growth
10.50%24.82%466.91%-52.40%-87.53%-11.26%
Accounts Receivable
35,51835,41735,02535,81334,18131,012
Other Receivables
317.62247.87754.7186.62123.85120.23
Receivables
35,83635,66535,77935,90034,30431,133
Inventory
32,88734,83334,77032,51124,74224,177
Prepaid Expenses
2,4641,84912,18911,159--
Other Current Assets
2,3583,1993,469638.2713,8326,140
Total Current Assets
74,73381,95891,34681,11574,78176,711
Property, Plant & Equipment
249,525242,715252,893242,198233,946103,394
Long-Term Investments
2,166819.59719.88797.39782.42838.64
Other Intangible Assets
3,6943,7274,7081,9173,1361,295
Long-Term Accounts Receivable
0-01,033000
Long-Term Deferred Charges
1,7041,755804.2902.04--
Other Long-Term Assets
40,51540,62743,56743,75044,05444,167
Total Assets
372,336371,602395,071370,680356,700226,405
Accounts Payable
20,53319,17819,15921,00413,6608,541
Accrued Expenses
5,2645,2814,0543,2824,01311,153
Short-Term Debt
90,02765,84654,18474,86880,56275,733
Current Portion of Long-Term Debt
27,09874,6109,16449,8304,94016,560
Current Portion of Leases
1,046731.38685.6387.37452.59308.27
Current Income Taxes Payable
341.06386.871,6462,4171,949-
Current Unearned Revenue
48.2497.29123.72112.34179.99171.28
Other Current Liabilities
19,37219,03117,64516,77426,8369,208
Total Current Liabilities
163,729185,163106,660168,675132,592121,674
Long-Term Debt
46,76521,61484,39049,56871,91831,911
Long-Term Leases
1,0901,2221,6591,2251,3871,003
Long-Term Unearned Revenue
2,0351,8886.2736.3866.15222.65
Pension & Post-Retirement Benefits
23,50421,92116,99111,3106,6261,646
Long-Term Deferred Tax Liabilities
4,6614,6617,4939,75213,172-
Other Long-Term Liabilities
1,9961,8701,7482,2865,1204,202
Total Liabilities
243,780238,340218,947242,853230,881160,658
Common Stock
10,84610,84610,8467,6136,8576,769
Additional Paid-In Capital
87,31186,43786,14544,00840,48135,248
Retained Earnings
-27,177-16,27919,93728,01926,60527,741
Treasury Stock
-1,749-2,517-2,517-4,161-4,142-5,431
Comprehensive Income & Other
59,32554,77661,71352,34956,0191,420
Shareholders' Equity
128,556133,262176,124127,827125,82065,746
Total Liabilities & Equity
372,336371,602395,071370,680356,700226,405
Total Debt
166,026164,023150,081175,879159,258125,515
Net Cash (Debt)
-164,838-157,611-144,944-174,973-157,355-110,254
Net Cash Per Share
-7758.38-7424.11-8059.84-12095.82-11286.13-7972.68
Filing Date Shares Outstanding
21.2821.2321.2314.4614.2513.77
Total Common Shares Outstanding
21.2821.2321.2314.4614.2513.77
Working Capital
-88,996-103,204-15,314-87,560-57,811-44,964
Book Value Per Share
6039.966277.178296.138838.318830.454776.06
Tangible Book Value
124,862129,535171,416125,911122,68364,451
Tangible Book Value Per Share
5866.426101.638074.388705.798610.324681.97
Land
64,48764,48764,48764,48767,1492,501
Buildings
150,791146,477149,90047,13647,15446,000
Machinery
89,95387,78987,69844,84643,17844,758
Construction In Progress
4,0751,91041.7132,199120,00955,341